SCHEMBL14015264

SCHEMBL14015264

CCC(CO)(CCc1ccc(Sc2cccc(OCc3ccccc3)c2)cc1Cl)NC(=O)OC(C)(C)C

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
S1PR1 P21453 4/20 0.58
S1PR3 Q99500 1/20 0.40
PDK1 Q15118 1/20 0.36
PDK2 Q15119 1/20 0.36
PDK3 Q15120 1/20 0.36
PDK4 Q16654 1/20 0.36
CYP2C9 P11712 1/20 0.35
PTGER1 P34995 1/20 0.35
KDM4E B2RXH2 1/20 0.35
MEN1 O00255 1/20 0.35
MAPT P10636 1/20 0.35
KMT2A Q03164 1/20 0.35
SPHK2 Q9NRA0 2/20 0.35
SPHK1 Q9NYA1 2/20 0.35
BCL2 P10415 2/20 0.34
MCL1 Q07820 1/20 0.34
MAOB P27338 1/20 0.34
PRKX P51817 1/20 0.34
ACVR1 Q04771 1/20 0.34
S1PR5 Q9H228 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2961626 0.96 S1PR1 (0.59) S1PR1S1PR3PDK1PDK2PDK3
SCHEMBL13240189 0.95 S1PR1 (0.55) S1PR1S1PR3PDK1PDK2PDK3
SCHEMBL1564038 0.93 S1PR1 (0.61) S1PR1S1PR3PDK1PDK2PDK3
SCHEMBL2963098 0.91 S1PR1 (0.55) S1PR1S1PR3PDK1PDK2PDK3
SCHEMBL1563356 0.90 S1PR1 (0.59) S1PR1S1PR3PDK1PDK2PDK3
SCHEMBL1563504 0.90 S1PR1 (0.52) S1PR1S1PR3PDK1PDK2PDK3
SCHEMBL1564193 0.90 S1PR1 (0.54) S1PR1S1PR3PDK1PDK2PDK3
SCHEMBL1562204 0.89 S1PR1 (0.50) S1PR1S1PR3CYP2C9PTGER1KDM4E
SCHEMBL2963654 0.88 S1PR1 (0.52) S1PR1S1PR3PDK1PDK2PDK3
SCHEMBL14015270 0.88 S1PR1 (0.57) S1PR1S1PR3PDK1PDK2PDK3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7456157-B2 Modulate sphingosine-1-phosphate (S1P) receptors with fewer side effects; for example, 2-amino-5-[4-(3-benzyloxyphenylthio)-2-chlorophenyl]-2-methylpentylphosphonic acid monoester; prophylactic or therapeutic agents against rejection of organ transplants, skin grafts, rheumatoid arthritis, lupus KYORIN PHARMACEUTICAL CO., LTD. (JP) 2008-11-25 US disclosed